Showing results (101-110 of 169) with videos related to
Sort By:
Pageof 17
Global Heart|November 30, 2014
The global burden of ischemic stroke: findings of the GBD 2010 studyDerrick A Bennett, Rita V Krishnamurthi, Suzanne Barker-Collo, et al.JAMA|April 4, 2018
Association of Solid Fuel Use With Risk of Cardiovascular and All-Cause Mortality in Rural ChinaKuai Yu, Gaokun Qiu, Ka-Hung Chan, et al.Global Heart|November 30, 2014
The global burden of hemorrhagic stroke: a summary of findings from the GBD 2010 studyRita V Krishnamurthi, Andrew E Moran, Mohammad H Forouzanfar, et al.International Journal of Epidemiology|October 29, 2023
MTHFR and risk of stroke and heart disease in a low-folate population: a prospective study of 156 000 Chinese adultsDerrick A Bennett, Sarah Parish, Iona Y Millwood, et al.Neuroepidemiology|September 22, 2015
Explanation and Elaboration of the Standards of Reporting of Neurological Disorders Checklist: A Guideline for the Reporting of Incidence and Prevalence Studies in NeuroepidemiologyDerrick A Bennett, Carol Brayne, Valery L Feigin, et al.European Journal of Preventive Cardiology|November 13, 2025
Polygenic prediction of coronary heart disease among 130,000 Mexican adultsTianshu Liu, Jaime Berumen, Jason Torres, et al.The Lancet. Diabetes & Endocrinology|October 13, 2025
Effects of empagliflozin on conventional and exploratory acute and chronic kidney outcomes: an individual participant-level meta-analysisWilliam G Herrington, Zhaojing J Che, Rebecca Sardell, et al.Eclinicalmedicine|July 21, 2025
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trialJunwen Zhou, Claire Williams, Natalie Staplin, et al.Circulation|February 28, 2024
Use of Artificial Intelligence in Improving Outcomes in Heart Disease: A Scientific Statement From the American Heart AssociationAntonis A Armoundas, Sanjiv M Narayan, Donna K Arnett, et al.Circulation. Genomic and Precision Medicine|August 29, 2019
Physical Activity, Sedentary Leisure Time, Circulating Metabolic Markers, and Risk of Major Vascular DiseasesYuanjie Pang, Christiana Kartsonaki, Huaidong Du, et al.Pageof 17